(Q38311635)

2 September 2017

title

Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

2 September 2017

main subject

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

Thomas S Weiss

7

0 references

author name string

Sabrina Krautbauer

1

1 reference

2 September 2017

Kristina Eisinger

2

1 reference

2 September 2017

Madeleine Lupke

3

1 reference

2 September 2017

Josef Wanninger

4

1 reference

2 September 2017

Petra Ruemmele

5

1 reference

2 September 2017

Yvonne Hader

6

1 reference

2 September 2017

Christa Buechler

8

1 reference

2 September 2017

publication date

22 October 2013

1 reference

Experimental and Molecular Pathology

2 September 2017

published in

1 reference

2 September 2017

volume

95

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

330-335

1 reference

Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Hepatic effects of a fructose diet in the stroke-prone spontaneously hypertensive rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Does global gene expression analysis in type 2 diabetes provide an opportunity to identify highly promising drug targets?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Manganese Superoxide Dismutase: A Hepatic Acute Phase Protein Regulated by Interleukin-6 and Glucocorticoids*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Superoxide dismutases: role in redox signaling, vascular function, and diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Direct effects of iodothyronines on excess fat storage in rat hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Prevalence, gender, ethnic variations, and prognosis of NASH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Use of transfected liver cells to evaluate potential mechanisms of alcohol-induced liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Testosterone-Down-Regulated Akt Pathway During Cardiac Ischemia/Reperfusion: A Mechanism Involving BAD, Bcl-2 and FOXO3a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Adiponectin upregulates ferritin heavy chain in skeletal muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Mechanisms of disease progression in nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Animal models of NASH: getting both pathology and metabolic context right

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Extracting time-dependent obese-diabetic specific networks in hepatic proteome analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

NIH Image to ImageJ: 25 years of image analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Identification of a novel biomarker for oxidative stress induced by hydrogen peroxide in primary human hepatocytes using the 2-nitrobenzenesulfenyl chloride isotope labeling method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

The role of cytokines in non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Induction of gene expression in response to globular adiponectin in vascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Iron state in association with retinoid metabolism in non‐alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Kupffer cells mediate leptin-induced liver fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

High-fat emulsion-induced rat model of nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.10.003

10.1016/J.YEXMP.2013.10.003

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference